THERAPEUTIC ACTIVITY OF PENICILLINS lv~ G~ K, AND X periments a preparation was used (Abbott 506A030) containing approximately 65 per cent of inert material, but in which penicillin K was said to constitute more than 90 per cent of the contained penicillin as determined by chromatographic adsorption (13) .
Baaerial Infections.--Mice weighing 18 to 22 gin., averaging 20 gin., were inoculated intraperitoneally with 0.2 cc. of diluted 18 to 24 hour blood-broth cultures of Streptococcus pyog~4es (strain C-203) or Pneumococcus Type I. The exact dilutions used as ifloculum and the minimum lethal dose represented by those dilutions are given in the tables.
Treatment with Penieillin.--Treatment with penicillin was begun 2 hours after inoculation, and was repeated every 3 hours to a total of ten injections. The dosages were varied serially twofold, using similarly varying concentrations in a fixed volume of 0.2 cc. per injection. Although the penicillin solutions were injected into the muscles of the hind leg, there was considerable leakage into the soft tissues, and the treatment should be considered a combination of intramuscular and subcutaneous administration.
Obser~ation.--Mice were observed for 7 to 14 days before being adjudged cured. Control animals died regularly in 24 to 48 hours; and the majority of the treatment failures had died within 3 to 5 days after the last injection of penicillin.
In Vitro Assays of Bactericidal Activity of Penicillins.--The method used for the assay of streptococcidal activity has been described in detail elsewhere (2, 5) .
The method used for the assay of pneumococcidal activity was a combination of turbidimetric and colorimetric, using 0.1 per cent dextrose-broth with an internal indicator (brom cresol purple in 0.003 per cent concentration). The medium was further enriched by the addition of one-tenth volume of heated (56°C. for 2 hours) rabbit serum. Varying amounts of a known dilution of penicillin in broth (0.8, 0.72, 0.06, 0.48, 0.4, etc. in a total volume of 0.8 cc.) were inoculated with 10.4 of a 1 : 1,000 dilution of a 24 hour culture. Results were read after 18 hours in the incubator; and the end-point was usually sharply demarcated, a clear tube with no visible growth and no change in indicator color being followed by a turbid tube in which there had been an obvious production of acid.
EXPERIMENTAL RESULTS

A. Therapeutic Activity of P~icillins F, G, K, and X in Pneumococca~ and Streptococcal Infections in White Mice
Pn~mococcd Infections.--In Table I are summarized the results of three experiments done at different times. Although the inoculum in those three >10 ~ experiments varied from a low of < 1@ ~.L.D. to a high of > 104 <105 M.L.D., the results in the three experiments did not differ significantly, and they have been combined in the table. A single lot each of penicillin F, G, and X was used throughout. Two lots of penicillin K (Abbott) were used, one a purified preparation, and one in which K was said to constitute more than 90 per cent of the active material, but which contained approximately 65 per cent inert ingredients (cf. above). The therapeutic activity of these two preparations differed by Jess than 25 per cent, and they have been pooled in Table I . The total curative doses (CDs0) of penicillins F, G, K, and X were 4.6, 3.8, 20, and 2.4 mg. per kg., respectively. These figures correspond to relative activities per milligram of 83, 100, 19, and 160, referred to G as 100. If the comparison is made on the basis of "units" instead of milligrams, the relative therapeutic activities of F, G, K, and X become 92, 100, 14, and 295, respectively. However expressed, penicillin X was clearly the most active of the four peniciUins, K was by far the least active, and F and G were essentially equal in activity.
TABLE I
Tie Therapeutic Activity of PeniczTlins F, G, K, and X in Pneumococcal Infections of White Mice
Mice weighing an average of 20 gin. (18 to 22 gm.) were inoculated intraperitoneally with 0.2 ec. of diluted 24 hour blood-broth culture of Type I pneumococci. Intramuscular treatment with penicillin (0.2 cc. per injection) was begun 2 hours later and repeated every 3 hours for ten doses. In three individual experiments, the dilutions used for inoculation were 1 : 500, 1:400, and 1:200, and these were found to contain 104, >10t and >10~ < 10~' < 10~ ~.r.n., respectively.
Despite the variations in the size of the inoculum, the therapeutic results did not vary signiticantly, and the three experiments have been pooled in the Table II. 1 a In a third small scale experiment carried out at a later date, in which the inocnium was 104 M.L.D., and in which the organisms were significantly less virulent, judged by the time required for death in the control animals, the curative doses of G, K, and X were consistently lower than in the first two experiments; but their relative activities referred to penicillin G as 100 (100, 12.5, and 320) agreed satisfactorily with those shown in Table II . The penicillin K used in this experiment was made by Pfizer, and was as inactive as the Abbott preparation used in the experiments of Table II. The total curative doses (CDs0) of peniclllins F, G, K, and X were 2.6, 1.3, 14.0, and 0.5 mg. per kg. These values correspond to relative activities of 50, 100, 9, and 260, respectively, referred to G as 100. If the penicillins are compared on the basis of units rather than milligrams, the relative therapeutic activities of F, G, K, and X become 54, 100, 7, and 480. Penicillin X was 
B. Corrdations between the Relative Bactericidal Activity of Penicillins F, G, K, and X in Vitro, and Their Therapeutic Efficacy in Vivo
If peniciUins F, G, K, and X were identical in their pharmacological behavior, their therapeutic efficacy would be determined solely by their relative bactericidal activity in v~tro. However, if one compares the activities of these penicillins against streptococci (or pneumococci) in vitro with their curative doses against the same organism in vivo, it becomes apparent that there are consistent and significant differences between the several penicillins with respect to that ratio.
Experiments to determine the relative bactericidal activity of penicillins F, G, K, and X are summarized in Table III . The comparison of their in vitro activity with their therapeutic efficacy is given in Table IV. 1. As is there shown, the greatest discrepancy between bactericidal activity and therapeutic efficacy is observed with penicillin K. In ~itro, penicillin K was 1.15 times more active than G against streptococci, and 2 times more active than G against pneumococci. Against the latter organism, it was the most active of the four penicillins here studied. In vivo, however, it was one-fifth as active as G against pneumococei, one-eleventh as active against streptococci, and in both cases, approximately one-tenth as effective as would be implied by its direct bactericidal activity in vitro.
The therapeutic inactivity of penicillin K, first noted by Chesney (9) and Mahoney and Arnold (10) in the treatment of experimental syphilis, is therefore not peculiar to that disease, but is observed in any infection, and reflects the anomalous pharmacologic behavior of penicillin K. This has been considered in detail in the foregoing two papers of this series (5, 6) . Like penicillins F, G, and X, penicillin K is inactivated by serum and plasma in vitro. Unlike those peniciUins, the rate of K inactivation accelerates as its concentration is reduced; and at concentrations of less than 1 microgram per cc., an effectively bactericidal level for most organisms and the usual therapeutic range, it is inactivated so rapidly as to be of little value. Because of a similar inactivation by blood and perhaps by the tissues in rico, it gives lower and more THERAPEUTIC ACTIVITY 017 PENICILLINS 17~ O~ K~ AND X evanescent blood curves than either F, G, or X. Thus, after the intramuscular injection in rabbits of 0.6 mg. per kg., plasma levels of 0.1 microgram per cc. or more were sustained for 0.5 hours, as compared with 1.4 for G and 2.1 for X. In man, the corresponding values after intravenous injection were 0.5, 1, and 1.3 hours. For a concentration of 0.1 microgram per cc., the disparity would be even greater. Corresponding to its rapid inactivation by serum and plasma Table II . § All activities have been referred to that of penicillin G as 100. of in ~i2ro: in vivo activity for penicillin G was 1.
[[ Cf. Table I. Of necessity, the ratio in vitro, and its rapid disappearance from the blood in vivo, the urinary recovery of active penicillin in rabbits averaged only 33 per cent for K, as compared with 61 for F, 87 for G, and 74 for X. The corresponding recoveries in man were 28 per cent for K, as compared with 86 and 93 per cent, for G and X, respectively. In summary, penicillin K is rapidly inactivated by blood or plasma, and presumably in consequence of a similar inactivation in vivo disappears from the circulating blood far more rapidly than F, G, or X. Corresponding to its rapid inactivation, the therapeutic efficacy of K in the two infections here studied averaged only one-tenth of its bactericidal activity against the same organisms in vitro.
2. In contrast to penicillin K, X was somewhat more effective therapeutically than one would have anticipated from its bactericidal action in vitro. Against streptococci, X was 1.45 times more active than G/n vitro, but 2.6 times more active in vivo (Table II) . Against pneumococci, X was 1.35 times more active than G in vitro, but 1.6 times more active in vivo. In both infections, X was more active therapeutically than would be implied by its bactericidal activity in vitro.
An adequate explanation is provided by the fact that, as shown in the preceding paper ( (6); cf. also references 3, 4, 7), penicillin X regularly gives higher and more sustained blood levels than does G in equal (gravimetric) dosage. In rabbits, intramuscular injections of 0.6 rag. per kg. provided levels of 0.1 microgram per cc. for 1.4 hours with G, and 2.1 hours with X. In man, the corresponding values were 1.6 and 2.3 hours, respectively. The more sustained plasma levels probably reflect the fact (5) that penicillin X is inactivated more slowly by serum and plasma, and perhaps by the body tissues, than is; e. g., penicillin G.
Although the foregoing differences seem slight, they are of considerable practical importance. The proportion of surviving organisms after exposure to a given concentration of penicillin for time t usually varies with the time as an exponential factor (8) . Even if one omits from consideration the somewhat higher average levels provided by X as compared with G, a 1.5-fold difference in the time for which a given concentration is maintained may represent more than a two-fold difference in the number of organisms surviving.
In summary, in the two infections here studied, penicillin X was more effective therapeutically than its bactericidal activity in vitro would imply, probably because it provides somewhat higher and more sustained blood levels than penicillin G administered in equal gravimetric dosage.
C. A Comparison of the Relative Susceptibility of Streptococci and Pneumococci to Penicillin in Vitro and in Vivo
One may assume as a working hypothesis that the therapeutic efficacy of penicillin rests primarily on its direct bactericidal action, and that the defense mechanisms of the host contribute but little to that therapeutic action. Under such circumstances., the widely varying curative dose of penicillin in different infections could be determined largely by the similarly varying susceptibility of the particular organisms. This is obviously an oversimplification, and fails to take cognizance of such important factors as the varying number of organisms to be killed, their possibly varying accessibility to penicillin, and the rapidity and extent of the patient's immune response. It is therefore of interest to note that in the experiments described in the present paper, the curative dose against a given penicillin was in fact directly related to the varying susceptibility of those organisms i n vitro.
TABLE V The Corrdalion between the Susceptibility of Streplococci and Pneumococd to PenicilUn in Vitro, and the Cura~i~ Dose in Vi~o
The factor under consideration is the relative susceptibility of different organisms to the same penicillin in vitro and in ~ivo. In the table, as well as in Fig. 1, comparisons Table V and Fig. 1 . The average minimum concentration of (e.g.) penicillin G which inhibited the growth of streptococci and pneumococci i n vitro under the conditions of the assay method here used was 0.01 and 0.019 microgram per cc., respectively. Corresponding to this twofold difference in the susceptibility of the organisms i n vitro, t h e curative doses of G in the two infections were 1.3 and 3.8 rag. per kg. W i t h penicillin X, a threefold difference in the inhibiting concentration for streptococci and pneumococci in vitro (0.005 and 0.016 microgram per cc.) was reflected in a fivefold difference in the curative dose (0.5 and 2.4 rag. per kg.); and a similar paraUelism was noted with penicillin F (inhibitory concentrations of 0.012 and 0.03 microgram per cc., and curative doses of 2.6 and 4.6 rag. per kg.). Penicillin K is not considered in Fig. 1 because of the complication introduced by its rapid inactivation in vi¢o. 
This is shown in
mykg.
FIo. 1. The correlation between the susceptibility of streptococci and pneumococci to penicillin gn vitro and the curative dose in ¢/¢o (after data of Table V) .
The implication is clear that the curative dose of penicillin in a given infection is in Large part determined by the susceptibility of the particular organism to peniciUin in vitro. It must nevertheless be emphasized that in the two experimental infections here studied, the host species, the method of inoculation, and the schedule of administration were identical throughout; the type of infection was similar (a massive fulminating septicemia), and comparable numbers of organisms had to be killed in order to effect cure (inocula of the same order of magnitude, 10' to 10 e ~.T..D., were used in all the experiments). Although the activity of penicillin in these controlled experimental infections paralleled its activity in vitro, wide differences in the inoculum or in the age of the infection would probably be reflected in a correspondingly varying curative dose; and if the organisms were at areas not readily accessible to penicillin, or if the immune response were of a different order of magnitude in time or extent, the susceptibility of the organism to penicillin might no longer be the factor which solely or even primarily determined the curative dose.
DISCUSSION
The data of the present and preceding papers indicate that in suitably controlled experiments the therapeutic activity of a given penicillin species in a given infection is materially affected by two factors: the intrinsic bactericidal action of the penicillin against the particular organism, as measured by its activity in vitro, and the pharmacological behavior of the penicillin in vivo, measured by the height and amplitude of the blood penicillin curve.
Of the four natural penicillins so far identified, X is the penicillin of choice in the treatment of streptococcal and pneumococcal infections. Not only is it intrinsically more active against these organisms than F or G ( (2); page 179); but in addition, milligram for milligram, penicillin X yields higher and more sustained blood levels than those penicillins (5, 3, 4, 7) ). In consequence, the curative dose of X in milligrams has been here found to be fourtenths that of G in streptococcal infections, and two-thirds that of G in pneumococcal infections. Compared on the basis of units rather than milligrams, X was therapeutically three times as active as G against pneumococci, and five times as active against streptococci. Against gonococci also, X has been found to be the most active of the four natural penicillins in vitro (II), and more effective than G in the treatment of the human disease (3) .
In vitro, penicillin K has perhaps the highest over-all activity of all four penicillins, being the most active against staphylococci (I) and pneumococci (page 179), and the second most active against streptococci (2) and spirochetes (2) . In vivo, however, it had only a minor therapeutic activity in two of these infections, due to the fact that it is rapidly inactivated in vivo, and provides significant blood levels for relatively short periods. The therapeutic inactivity of K thus has a pharmacological basis, is observed in every infection so far studied, and removes that penicillin from serious consideration as a therapeutic agent for systemic administration. It may perhaps be of value in topical application, if it is present in sufficient concentration (the rate of inactivation varies inversely with its concentration), and particularly if exudates are found to be less active than is serum in its inactivation.
The commercial production of penicillin has already gone through several stages. At the present writing, the trend is to the production of a highly refined and perhaps crystalline product, consisting almost entirely of penicillin G. This has certain definite advantages. It permits the administration of penicillin on a gravimetric basis, as a drug, instead of on an arbitrary scale of staphylococcidal units w~aich has no necessary m~aning in other infections. Equally important, penicillin G is the major single penicillin component produced by the presently available strains of mold. The proportion of G relative to the other penicillins can be further increased by the addition of suitable precursor substances to the nutrient medium, and it is formed in the deep tank cultures which facilitate large scale production.
It must nevertheless be emphasized that in many infections, penicillin G is not the penicillin of choice. Of the three natural penicillins which are to be considered, F, G, and X, penicillin G is known to be distinctly inferior to X in the treatment of at least three infections (streptococcal, pneumococcal, and gonococcal). If the difference between G or X were solely quantitative, this would be of only minor importance. Thus, if it required 120,000 units of G as compared to 25,000 units of X to cure a case of gonorrhea, or if it required 800,000 units of G instead of 200,000 units of X to cure a case of pneumonia, the problem would simply be one of adequate dosage. There is, however, a real possibility that the difference may be qualitative as well as quantitative. It may well be that of 100 cases of subacute bacterial endocarditis, perhaps only e.g. 70 can be cured with G, no matter in what dosage it is employed, while perhaps 90 could be cured with X. This qualitative difference cannot be studied in animals, for in the experimental infections susceptible to penicillin, all the animals (> 95 per cent) are cured if adequate doses are administered. It can, however, be studied in man, given an adequate supply of the pure penicillins.
The fact that such wide differences in bactericidal activity and pharmacological behavior have been demonstrated among the first four natural penicRlius to be identified suggests that additional penicillins may yet be discovered which are more active against specific organisms, or have more favorable pharmacological properties, than any of those now available. SuMMARy 1. The relative bactericidal activities of penicillins F, G, K, and X against Type I pneumococcus in dtro were 60, 100, 180, and 135. The corresponding activities against Streptococcus pyogenes, strain C-203, were 75, 100, 115, and 145, respectively.
2. The total curative doses (CDs0) of penicillins F, G, K, and X in pneumococcal infections of white mice (ten injections at 3 hour intervals) were 4.6, 3.8, 20, and 2.4 mg. per kg., respectively, or relative activities of 83, 100, 19, and 160, referred to G as 100.
3. The corresponding curative doses in streptococcal infections of white mice were 2.6, 1.3, 14.0, and 0.5 mg. per kg., or relative activities of 50, 100, 9, and 260.
4. Penicillin K was therefore one-tenth as active in ~vo as would be implied by its bactericidal activity in vitro. This probably reflects its rapid inactivation in vivo, evidenced by the low and evanescent blood levels observed in both rabbits and man, and the low urinary recovery of this species of penicillin.
5. Penicillin X was significantly more active therapeutically than its bactericidal activity in vitro would imply. This probably reflects its slower inactivation in rico, evidenced by the somewhat higher and more prolonged blood levels afforded by this penicillin in comparison with penicillin G. judged by the mouse infections with the strains here used, penicillin X is the penicillin of choice in the treatment of infections with pneumococcus Type I and hemolytic streptococci.
6. The curative dose of penicillin in streptococcal and pneumococcal infections paralleled the varying susceptibility of these organisms to penicillin in vitro.
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